Kalthera Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Kalthera General Information

Description

Developer of chimeric antigen receptor (CAR T-cell) therapies based in Los Angeles, California. The company offers clinical programs and CAR engineering expertise, thereby providing its patients with safe and effective cures against cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Los Angeles, CA
  • United States
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Los Angeles, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kalthera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kalthera‘s full profile, request access.

Request a free trial

Kalthera FAQs

  • Where is Kalthera headquartered?

    Kalthera is headquartered in Los Angeles, CA.

  • What industry is Kalthera in?

    Kalthera’s primary industry is Biotechnology.

  • Is Kalthera a private or public company?

    Kalthera is a Private company.

  • What is Kalthera’s current revenue?

    The current revenue for Kalthera is .

  • When was Kalthera acquired?

    Kalthera was acquired on 22-Jul-2021.

  • Who acquired Kalthera?

    Kalthera was acquired by ImmPACT Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process